PJT Partners
PJT
$145.01
-4.37%
PJT Partners Inc. is an advisory-focused investment bank providing strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, and governments globally, operating within the Financial - Capital Markets industry. The firm is a distinct, pure-play advisory boutique, carving out a niche by focusing on high-value, conflict-free advisory work rather than traditional trading and lending activities. The current investor narrative centers on the company's resilience and strategic positioning as a go-to advisor for complex corporate transactions, with attention likely focused on how its performance is navigating the broader macroeconomic and capital markets environment, particularly given its exposure to M&A and restructuring cycles.…
PJT
PJT Partners
$145.01
Investment Opinion: Should I buy PJT Today?
Rating: Hold. The core thesis is that PJT is a fundamentally sound company trapped in a cyclical downturn and suffering from poor market sentiment, making it a value candidate for patient investors but lacking a near-term catalyst for a sustained rally.
Supporting evidence includes its attractive forward P/E of 17.8x, which discounts expected earnings growth, and a PEG ratio of 0.73 suggesting undervaluation relative to growth. The company's profitability is strong, with a 21.2% operating margin and a stellar return on equity of 58.4%. Furthermore, its balance sheet is a key strength, with an extremely high current ratio of 27.67 indicating no liquidity concerns. However, the stock's -2.95% 1-year return versus the market's 22.86% gain underscores the severe sentiment headwind.
The thesis would upgrade to a Buy if the forward P/E compressed further toward 15x on sustained earnings growth, or if quarterly results demonstrate a clear inflection in advisory revenue, breaking the technical downtrend. It would downgrade to a Sell if revenue visibility deteriorates, pushing the stock below its key support at $127.73. Based on the available data, the stock appears fairly valued to slightly undervalued given its strong fundamentals, but the cyclical overhang and lack of momentum warrant caution.
Sign up to view all
PJT 12-Month Price Forecast
The assessment is neutral based on a clash between compelling fundamentals and weak price action. The company's high-quality financial profile—evidenced by stellar ROE, strong margins, and a fortress balance sheet—suggests deep value. However, the stock's persistent downtrend, significant underperformance versus the market, and dependence on a cyclical revenue stream create a substantial overhang. The stance would upgrade to bullish on concrete evidence of revenue acceleration or a sustained technical breakout above $163. It would turn bearish if the next earnings report shows margin compression or a guidance cut, confirming cyclical pressures are intensifying.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on PJT Partners's 12-month outlook, with a consensus price target around $188.51 and implied upside of +30.0% versus the current price.
Average Target
$188.51
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$116 - $189
Analyst target range
Analyst coverage for PJT is extremely limited, with data indicating only one covering analyst, which constitutes insufficient coverage for deriving a meaningful consensus. This minimal coverage typically implies the stock is a smaller or more niche player with limited institutional interest, which can lead to higher volatility and less efficient price discovery. The provided data includes estimated EPS and revenue ranges but lacks explicit price targets, buy/sell/hold ratings, or a target price range, preventing any calculation of implied upside or analysis of analyst sentiment dispersion.
Bulls vs Bears: PJT Investment Factors
The evidence currently tilts bearish, primarily due to the stock's persistent technical weakness and significant underperformance relative to the market over the past year. However, compelling bullish arguments exist in the company's strong fundamentals, including high profitability, attractive forward valuation, and a rock-solid balance sheet. The single most important tension in the investment debate is whether the company's cyclical advisory business can reignite growth to justify a valuation re-rating, or if the current price accurately reflects a prolonged period of subdued capital markets activity. The resolution of this growth versus cyclicality question will dictate the stock's direction.
Bullish
- Strong Profitability and Cash Flow: The company exhibits robust underlying profitability with a trailing net margin of 10.5% and an operating margin of 21.2%. This is supported by a healthy price-to-cash-flow ratio of 8.17x, indicating the business efficiently converts earnings into cash for shareholders.
- Attractive Forward Valuation: The stock trades at a forward P/E of 17.8x, a significant discount to its trailing P/E of 23.9x, implying the market expects earnings growth. This forward multiple, combined with a PEG ratio of 0.73, suggests the stock may be undervalued relative to its growth prospects.
- Exceptional Balance Sheet Liquidity: PJT maintains an exceptionally strong liquidity position with a current ratio of 27.67, indicating ample short-term assets to cover liabilities. This fortress balance sheet provides significant resilience against market downturns and funds strategic initiatives without external financing.
- High Short Interest and Low Beta: A short ratio of 4.44 indicates significant bearish positioning, which could fuel a sharp rally on any positive catalyst. Coupled with a beta of 0.84, the stock is historically less volatile than the market, offering a defensive characteristic within a cyclical industry.
Bearish
- Severe Underperformance vs. Market: PJT has significantly underperformed the broader market, with a 1-year price change of -2.95% compared to the SPY's gain of 22.86%. This -25.8% relative strength deficit highlights persistent investor skepticism and selling pressure.
- Pronounced Technical Downtrend: The stock is in a clear downtrend, trading 22% below its 52-week high and having experienced a maximum drawdown of -32.6%. The recent 1-month decline of -1.56% and 6-month drop of -10.3% suggest the recovery attempt remains fragile.
- Minimal Analyst Coverage and Visibility: With only one covering analyst, the stock suffers from limited institutional interest and poor price discovery, which can lead to higher volatility. The lack of a consensus price target or rating makes it difficult to gauge Wall Street's confidence in the forward outlook.
- Cyclical Business Model Risk: As a pure-play advisory boutique, PJT's revenue is highly dependent on M&A and restructuring cycles. The company's performance is inherently tied to capital markets activity, making it vulnerable to macroeconomic slowdowns and declines in corporate deal-making.
PJT Technical Analysis
The stock is in a pronounced downtrend over the past year, with a 1-year price change of -2.95%, significantly underperforming the SPY's 22.86% gain. As of the latest close of $152.37, the price is trading near the lower end of its 52-week range, approximately 22% above the 52-week low of $127.73 and 22% below the 52-week high of $195.62, indicating the stock is in a value-seeking zone but remains under significant pressure. Recent momentum shows a complex picture, with a strong 3-month gain of 17.93% suggesting a potential recovery attempt, yet this is contradicted by a 1-month decline of -1.56% and a 6-month drop of -10.28%, signaling that any recovery remains fragile and susceptible to renewed selling pressure. Key technical support is clearly defined at the 52-week low of $127.73, while resistance looms at the 52-week high of $195.62; a decisive break below support would signal a continuation of the bearish trend, whereas a sustained move above the recent recovery highs near $163 could indicate a trend reversal. With a beta of 0.84, the stock has historically been 16% less volatile than the broader market, which, coupled with a high short ratio of 4.44, suggests the potential for sharp moves on any positive catalyst.
Beta
0.84
0.84x market volatility
Max Drawdown
-32.6%
Largest decline past year
52-Week Range
$128-$196
Price range past year
Annual Return
-12.9%
Cumulative gain past year
| Period | PJT Return | S&P 500 |
|---|---|---|
| 1m | -5.2% | -2.0% |
| 3m | +3.8% | +13.9% |
| 6m | -13.3% | +8.7% |
| 1y | -12.9% | +20.5% |
| ytd | -14.5% | +8.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PJT Fundamental Analysis
Revenue and growth trajectory analysis is constrained as specific quarterly revenue figures and YoY growth rates are not available in the provided data; however, analyst estimates point to expected annual revenue of approximately $2.35 billion, indicating the market is modeling a substantive business scale. The company is profitable, with a trailing net margin of 10.5% and an operating margin of 21.2%, while its gross margin stands at 32.4%, suggesting a healthy underlying profitability profile for an advisory business. The balance sheet and cash flow health appear strong on a liquidity basis, evidenced by an exceptionally high current ratio of 27.67, indicating ample short-term assets relative to liabilities, though the debt-to-equity ratio of 1.34 shows a moderate level of financial leverage; the price-to-cash-flow ratio of 8.17 and a return on equity of 58.4% suggest the company is generating robust cash returns for shareholders.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PJT Overvalued?
Given the company's clear profitability with a positive net margin, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 23.9x and a forward PE of 17.8x; the discount of the forward multiple suggests the market anticipates earnings growth in the coming year. Comparing to sector averages is not possible as industry average multiples are not provided in the data, preventing a determination of whether PJT trades at a premium or discount to its peers. Historical context for the valuation is also unavailable due to missing historical ratios data, so an assessment of whether the current PE is near the top or bottom of its own historical range cannot be made.
PE
23.9x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: PJT's primary financial risk is not leverage or liquidity—its debt-to-equity of 1.34 is moderate and its current ratio of 27.67 is exceptionally strong—but rather revenue volatility inherent to its business model. As an advisory firm with an estimated $2.35 billion in revenue, its income is directly tied to the volume of high-value M&A and restructuring transactions, which are highly cyclical and can lead to significant earnings swings. The lack of a diversified revenue stream beyond advisory fees exposes the company to sharp downturns during periods of market stress, as evidenced by its trailing net margin of 10.5%, which could compress rapidly in a deal drought.
Market & Competitive Risks: The stock faces significant valuation compression risk if the anticipated earnings growth implied by its forward P/E of 17.8x fails to materialize. Trading at a price-to-book ratio of 13.95x, the market is pricing in substantial future returns on equity, which currently stand at a high 58.4%. A reversion to a lower multiple would pressure the stock price. Furthermore, the boutique advisory space is competitive, and PJT must continually compete for top talent and mandates against larger, full-service banks and other independents. Its low beta of 0.84 suggests it is somewhat defensive, but it remains susceptible to sector-wide outflows from financials.
Worst-Case Scenario: The worst-case scenario involves a severe and prolonged downturn in global capital markets, leading to a collapse in M&A and restructuring activity. This would cause revenue and earnings to fall sharply, compressing the forward P/E multiple. Combined with its low analyst coverage leading to a loss of investor interest, the stock could re-test its 52-week low of $127.73. From the current price of $152.37, this represents a realistic downside of approximately -16%. A reversion to the recent March low near $129 would imply a -15% loss, aligning with the stock's demonstrated max drawdown of -32.6%.
FAQ
The key risks are, in order of severity: 1) Cyclical Revenue Risk: Revenue is entirely dependent on volatile M&A and restructuring fees, which can collapse in a downturn. 2) Sentiment and Technical Risk: The stock is in a sustained downtrend with a -32.6% max drawdown, and poor relative performance can lead to further outflows. 3) Low Visibility Risk: With only one covering analyst, the stock has limited institutional support and can experience sharp moves on thin news. 4) Valuation Compression Risk: If expected earnings growth does not materialize, the forward P/E multiple of 17.8x could contract, pressuring the share price.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $150 and $170, as stable execution meets ongoing cyclical concerns. The Bull Case (25% probability) targets $185 to $195, driven by a deal-making resurgence and multiple expansion. The Bear Case (15% probability) risks a drop to $127-$140 if the macro environment worsens. The Base Case is most likely, predicated on the assumption that capital markets activity remains muted but does not deteriorate further. The key variable is the timing and strength of the recovery in PJT's core advisory markets.
Based on the available data, PJT appears fairly valued to slightly undervalued. The forward P/E of 17.8x represents a meaningful discount to the trailing P/E of 23.9x, implying the market is paying for future earnings growth. The PEG ratio of 0.73 typically signals undervaluation. However, without sector average multiples for comparison, it's difficult to definitively call it cheap. The valuation implies the market expects a recovery in earnings but remains skeptical about the sustainability of growth given the cyclical nature of the advisory business. The high price-to-book ratio of 13.95x reflects the market's pricing of its exceptional return on equity.
PJT is a conditional buy for patient, value-oriented investors. Its strong fundamentals—including a 58.4% ROE, 21.2% operating margin, and forward P/E of 17.8x—present a compelling value case. However, it is not a good buy for those seeking near-term momentum, as the stock is in a pronounced downtrend and has underperformed the market by over 25% in the past year. The high short ratio of 4.44 could lead to a sharp rally on positive news, but the biggest risk is a prolonged slump in capital markets activity. It is a good buy only if you believe the cycle will turn within your investment horizon.
PJT is more suitable for a long-term investment horizon of 3+ years rather than short-term trading. Its business is tied to multi-year capital markets cycles, and realizing the value from its strong fundamentals likely requires patience for the cycle to turn. The stock's low beta of 0.84 suggests lower volatility, which is better for holding, while its minimal dividend yield (0.57%) does not provide income for short-term holders. The lack of near-term catalysts and poor technical momentum make it a challenging short-term trade. A long-term horizon allows investors to weather the cyclicality and potentially benefit from a valuation re-rating as earnings compound.